Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael

Showing results (931-940 of 1,001) with videos related to

Pageof 101
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 18, 2026
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis FoundationManju Chandran, Athanasios D Anastasilakis, Robert D Blank, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 26, 2006
Is it ethical to use placebos in osteoporosis trials?Sergio Ragi-Eis, Cristiano A F Zerbini, José R Provenza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2016
Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis StudyDavid W Dempster, Hua Zhou, Robert R Recker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2005
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE studyPaul D Miller, Michael R McClung, Liviu Macovei, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 30, 2006
Standards for performing DXA in individuals with secondary causes of osteoporosisAliya A Khan, David A Hanley, John P Bilezikian, et al.
Circulation|July 13, 2011
Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesionChenell Donadee, Nicolaas J H Raat, Tamir Kanias, et al.
The New England Journal of Medicine|September 20, 2016
Romosozumab Treatment in Postmenopausal Women with OsteoporosisFelicia Cosman, Daria B Crittenden, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2017
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA StudyDavid W Dempster, Hua Zhou, Robert R Recker, et al.
Bioinformatics (Oxford, England)|July 14, 2020
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problemErfan Sadeqi Azer, Farid Rashidi Mehrabadi, Salem Malikić, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) regionHo Yin Lo, Peter A Nemoto, Jin Mi Kim, et al.
Pageof 101

Showing results (931-940 of 1,001) with videos related to

Sort By:
Pageof 101
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 18, 2026
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis FoundationManju Chandran, Athanasios D Anastasilakis, Robert D Blank, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 26, 2006
Is it ethical to use placebos in osteoporosis trials?Sergio Ragi-Eis, Cristiano A F Zerbini, José R Provenza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2016
Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis StudyDavid W Dempster, Hua Zhou, Robert R Recker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2005
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE studyPaul D Miller, Michael R McClung, Liviu Macovei, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 30, 2006
Standards for performing DXA in individuals with secondary causes of osteoporosisAliya A Khan, David A Hanley, John P Bilezikian, et al.
Circulation|July 13, 2011
Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesionChenell Donadee, Nicolaas J H Raat, Tamir Kanias, et al.
The New England Journal of Medicine|September 20, 2016
Romosozumab Treatment in Postmenopausal Women with OsteoporosisFelicia Cosman, Daria B Crittenden, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2017
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA StudyDavid W Dempster, Hua Zhou, Robert R Recker, et al.
Bioinformatics (Oxford, England)|July 14, 2020
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problemErfan Sadeqi Azer, Farid Rashidi Mehrabadi, Salem Malikić, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) regionHo Yin Lo, Peter A Nemoto, Jin Mi Kim, et al.
Pageof 101